| abstract |
Provided herein are antibacterial compounds, wherein in some embodiments the compounds have a broad spectrum of biological activity. In various embodiments, the compounds act by inhibiting lipoprotein signal peptidase II (LspA), a key protein in bacteria. Also provided are pharmaceutical compositions and methods of treatment using the compounds described herein. |